GB0017940D0 - Use of radio-labelled antibody to bacterial compounds in the diagnosis of focal infection in humans - Google Patents

Use of radio-labelled antibody to bacterial compounds in the diagnosis of focal infection in humans

Info

Publication number
GB0017940D0
GB0017940D0 GB0017940A GB0017940A GB0017940D0 GB 0017940 D0 GB0017940 D0 GB 0017940D0 GB 0017940 A GB0017940 A GB 0017940A GB 0017940 A GB0017940 A GB 0017940A GB 0017940 D0 GB0017940 D0 GB 0017940D0
Authority
GB
United Kingdom
Prior art keywords
humans
diagnosis
radio
labelled antibody
bacterial compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB0017940A
Other versions
GB2356402A (en
GB2356402B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GB0017940A priority Critical patent/GB2356402B/en
Publication of GB0017940D0 publication Critical patent/GB0017940D0/en
Publication of GB2356402A publication Critical patent/GB2356402A/en
Application granted granted Critical
Publication of GB2356402B publication Critical patent/GB2356402B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/60—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances involving radioactive labelled substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1009—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against material from bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
GB0017940A 2000-07-22 2000-07-22 Use of radio-labelled antibody to bacterial compounds in the diagnosis of focal infection in humans Expired - Fee Related GB2356402B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0017940A GB2356402B (en) 2000-07-22 2000-07-22 Use of radio-labelled antibody to bacterial compounds in the diagnosis of focal infection in humans

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0017940A GB2356402B (en) 2000-07-22 2000-07-22 Use of radio-labelled antibody to bacterial compounds in the diagnosis of focal infection in humans

Publications (3)

Publication Number Publication Date
GB0017940D0 true GB0017940D0 (en) 2000-09-13
GB2356402A GB2356402A (en) 2001-05-23
GB2356402B GB2356402B (en) 2001-10-31

Family

ID=9896095

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0017940A Expired - Fee Related GB2356402B (en) 2000-07-22 2000-07-22 Use of radio-labelled antibody to bacterial compounds in the diagnosis of focal infection in humans

Country Status (1)

Country Link
GB (1) GB2356402B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1470237A4 (en) * 2001-12-21 2006-02-01 Biosynexus Inc Multifunctional monoclonal antibodies directed to peptidoglycan of gram-positive bacteria

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4566769A (en) * 1982-12-29 1986-01-28 Olympus Optical Co., Ltd. Power supply unit for electronic flash
US4888279A (en) * 1984-12-21 1989-12-19 Thomas Jefferson University Novel immunosorbent assays employing antibiotic keying agents
US5177192A (en) * 1987-04-02 1993-01-05 Centocor, Incorporated Method for labeling antibodies with a metal ion
US5328679A (en) * 1988-04-01 1994-07-12 Immunomedics, Inc. Methods for technetium/rhenium labeling of proteins
US5840272A (en) * 1992-06-09 1998-11-24 Perimmune Holdings, Inc. Imaging infectious foci with human IgM 16.88

Also Published As

Publication number Publication date
GB2356402A (en) 2001-05-23
GB2356402B (en) 2001-10-31

Similar Documents

Publication Publication Date Title
LTPA2020001I1 (en) Anti-IL-12 Antibodies, Compositions, Techniques, and Use for the Treatment of Crohn's Pathology
AU9549001A (en) Antibodies to human IL-1beta
HK1050013A1 (en) ANTIBODIES TO HUMAN IL-1β
IL144578A0 (en) Antibodies specific to kdr and uses thereof
IL166809A (en) Liquid aqueous formulations comprising human anti-tnf alpha antibodies
IS6779A (en) Human antibody against LT-beta-R
IL155092A0 (en) Compounds useful in the treatment of inflammatory diseases
IL153721A0 (en) Antibodies to human mcp-1
HUP0302376A3 (en) Anti-tnf antibodies, compositions, methods and uses
MA27126A1 (en) 3'PROMEDICAMENTS OF 2'-DESOXY- β-L-NUCLEOSIDES
HUP0402333A3 (en) Modified anti-tnf alpha antibody
ATE553129T1 (en) ANTIBODIES TO HUMAN IL-12
FR2809312B1 (en) USE OF L. CASEI IN IMMUNOSTIMULATING COMPOSITIONS
ID26300A (en) OBJECTIVE ABSORPTION ONCE USE
GB0007333D0 (en) Novel compounds and their manufacture and use
GB2356402B (en) Use of radio-labelled antibody to bacterial compounds in the diagnosis of focal infection in humans
FR2851379B1 (en) CONVERTER IN DIRECT TRANSFER OF ENERGY
NO20031036D0 (en) Preparations for the diagnosis of extra-pancreatic secretory function
AR028262A1 (en) HUMAN FAP-ALFA SPECIFIC ANTIBODIES
AU2002308707A1 (en) Efficient use of detectors with long dead times
FR2818131B1 (en) COSMETIC COMPOSITION COMPRISING HEPARANASE
SE0002629D0 (en) Novel compounds and their use
GB0001116D0 (en) Diagnosis of toxicoinfectious clostridiosis
ITVR20030117A1 (en) PROCESSING SYSTEM USING THE BRUSH USE
ITRM20000149V0 (en) ORAL HYGIENE ARTICLE.

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20040722